+ All Categories
Home > Documents > Course IC 29 - Official ESCRS · Course IC 29 – Cross-Linking – Vinciguerra - 4 2 31 4 5...

Course IC 29 - Official ESCRS · Course IC 29 – Cross-Linking – Vinciguerra - 4 2 31 4 5...

Date post: 05-Sep-2018
Category:
Upload: vanthuan
View: 222 times
Download: 0 times
Share this document with a friend
12
Course IC 29 – Cross-Linking – Vinciguerra - 1 XXXI Congress of the ESCRS 5 - 9 October, 2013 Amsterdam, The Netherlands Course IC 29 Successful Cross-Linking: Managing Complications, Pediatric Patients, Post-Refractive Surgery Ectasia, Thin Corneas and Long-Term Follow-Up (EBO Accredited) Senior Instructor: Paolo Vinciguerra, MD Associate Instructors: Jorge L. Alio, MD Leonardo Mastropasqua, MD Fabrizio I. Camesasca, MD 6 October 2013 8.00 – 10.00
Transcript

Course IC 29 – Cross-Linking – Vinciguerra - 1

XXXI Congress of the ESCRS

5 - 9 October, 2013

Amsterdam, The Netherlands

Course IC 29

Successful Cross-Linking: Managing Complications,

Pediatric Patients, Post-Refractive Surgery Ectasia,

Thin Corneas and Long-Term Follow-Up (EBO Accredited)

Senior Instructor: Paolo Vinciguerra, MD

Associate Instructors:

Jorge L. Alio, MD Leonardo Mastropasqua, MD Fabrizio I. Camesasca, MD

6 October 2013 8.00 – 10.00

Course IC 29 – Cross-Linking – Vinciguerra - 2

INDEX

I. Cross-Linking Safety Measures Fabrizio I. Camesasca, MD

Page 3

II. Cross-Linking Long-Term Outcomes and Age Groups Paolo Vinciguerra, MD

Page 5

III. Simoultaneous Custom Ablation and Cross-Linking Paolo Vinciguerra, MD

Page 8

ADDRESSES ............................................................................................................................. Page 19

Course IC 29 – Cross-Linking – Vinciguerra - 3

I. Cross-Linking Safety Measures

CXL: Safety Measures

Fabrizio I. Camesasca, MD

Paolo Vinciguerra, MD

Silvia Trazza, Orthoptist

Istituto Clinico Humanitas

University of Milan , Italy

Safety Measures 1. Prevention of infections

2. Incorrect vs. correct applications: maps and

OCT

3. Complications due to technical error:

1. Inadequate impregnation

2. Incorrect focusing

3. Home‐made solutions

4. Insufficient hydration

4. Inadequate follow up

Safety Measures Prevention of Infections

• When the epithelium is removed, corneal defences are

hampered

• During epithelial healing cornea is vulnerable to

infections

• Ten reports in literature (Step epi, Escherichia Coli, etc.)

• Pursue sterile conditions

• Postop therapy similar to refractive surgery

• Daily check of patients until reepithelialization

• Provide adequate hygiene instructions !

Safety Measures

Incorrect vs. Correct Applications

• Preventing unnecessary failures

• Adequate patient selection

• Anatomical features: use of

maps and OCT

Corneal opacity: no CXL !! Severe corneal opacities

Age: are older pts bad candidates?

No magic answer Like in every pt: look at

progression No progression: no treatment is

needed

Progression: why let the cornea worsen ?

Fluctuation of area/power of KC from 1°examination to pre CXL in 67 year‐old patient

6 mos later 12mos later

1°examination 2°examination 3°examination

Differential map + 6.36 D in 1 yr

Fluctuation of pachymetry of KC from 1°examination to pre CXL in 67 year‐old patient

6 mos later 12 mos later

1°examination 2°examination 3°examination

Differential Pachimetry map ‐70 microns in 1 yr

Progression KC: 72‐yrs old! Keratoconus: post CXL transition line over time in different pts

83µ

TE CXL

1 day post cxl te

340μ in cornea

292μ in cornea

2007 2008 2009

1 yrs post cxl

2 yrs post cxl

160µ

1 days post cxl te

404μ in cornea 328μ in cornea

144µ

2 days post cxl te

+1,2 d

+2,58 d

3 yrs post cxl

3,5 yrs post cxl

Course IC 29 – Cross-Linking – Vinciguerra - 4

2 3 4 5

Pachimetria

Pachimetria 470,77 406,85 345,58 427,77 452,67

Pachimetria

[email protected] press, Journal of Refractive

mic

rons

1. Intraoperative Pachimetry Opacity and Corneal Edema post CXL Safety Measures

490 470 450 430 410 390

370 350 330 310

470,77

-13.41%

406,85

345,58

427,77

452,67 -3.84%

453 pts

Complications due to technical errors

1. Incorrect focusing / irradiation

2. Inadequate impregnation 290 270 250

-28.94% +5.14%

-15.05 % +9.13 %

1 p<0.001 p<0.001 p<0.001 p>0.2

3. Insufficient hydration

Pre op Sine epi 20 min espans Fine UVA 4. Home‐made solutions

1. Incorrect Focusing

• Corneal Burns

• Erroneous UV calibration

• Inadequate UV focusing

• Distance: verify regularly

• UV rays: orthogonal to iris plane

[email protected]

1. Incorrect Focusing • Corneal Burns

• Riboflavin shield effect:

• reduces gradually UV power (3.0 mW/cm2)

down to 3% of irradiance at 400 μ of

corneal thickness (0.09 mW/cm2)

2. Inadequate Impregnation • Insufficient: reduced shield

• Prolonged: shield not increased below 3%,

induced dehydration with secondary thinning

[email protected]

Corneal Burn: Oblique Irradiation

Marked flattening

Day 5, RE

Corneal Burn: Excessive Flattening

PRE CXL OD BSCVA: 0.8 ‐1,25@94

POST CXL OD BSCVA: 0.6 +7,00 ‐1,00@90

3. Insufficient Hydration

• Delay in Reepithelialization

• Poor application of selection criteria

• Metabolic diseases (diabetes, hypothyroidism)

• Dry eye

• Stem cell insufficiency

• Steep corneas

‐ tear film rupture

• Insufficient corneal hydration during irradiation

(4% hyaluronic acid)

Delay in Reepithelialization

due to corneal burn

6 mos: disappearence of flattening and hyperopia [email protected] [email protected]

Helping Reepithelialization

•Contact lens

• adequate ray of curvature in very

steep corneas

• careful application, massage, check

position

• Aminoacids pre‐load

[email protected]

Conclusions

• Cross‐Linking is a

generally very safe

procedure

• Beware of technical

errors ! [email protected]

Course IC 29 – Cross-Linking – Vinciguerra - 5

VIN

CIE

YE

II. Cross-Linking Long-Term Outcomes and Age Groups

CXL PAPERS PHASE I 2000 Dresda

Cross linking: long term outcomes and

age groups P. Vinciguerra MD;

S. Trazza Orth. Istituto Clinico Humanitas

Rozzano, MI, Italy Chairman: Paolo Vinciguerra, MD

1. Refractive, topographic, tomographic, and aberrometric analysis of keratoconic eyes undergoing corneal cross‐linking.

Vinciguerra P, Albè E, Trazza S, Rosetta P, Vinciguerra R, Seiler T, Epstein D.

Ophthalmology. 2009 Mar;116(3):369‐78.

1. Intraoperative and postoperative effects of corneal collagen cross‐linking on progressive keratoconus.

Vinciguerra P, Albè E, Trazza S, Seiler T, Epstein D.

Arch Ophthalmol. 2009 Oct;127(10):1258‐65.

Corneal Collagen Cross‐Linking for Ectasia After Excimer Laser Refractive Surgery: 1‐Year Results.

Vinciguerra P, Camesasca FI, Albè E, Trazza S.

J Refract Surg. 2009 Sep 22:1‐12.

Intra‐ and Postoperative Variation in Ocular Response Analyzer Parameters in Keratoconic Eyes After Corneal Cross‐Linking.

Vinciguerra P, Albè E, Mahmoud AM, Trazza S, Hafezi F, Roberts CJ.

J Refract Surg. 2010 Apr 28:1‐8.

Scheimpflug imaging of corneas after collagen cross‐linking.

Koller T, Iseli HP, Hafezi F, Vinciguerra P, Seiler T.

Cornea. 2009 Jun;28(5):510‐5.

Massive remodellingof the antherior corneal surface following collagen cross linking with riboflavine and UVA

Farhad Hafezi M.D., Thobiad Koller M.D.; Paolo Vinciguerra M.D, Theo Seiler, Phd, M.D.

The role of amino acids in corneal stromal healing: a method for evaluating cellular density and extracellular matrix distribution.

Torres Munoz I, Grizzi F, Russo C, Camesasca FI, Dioguardi N, Vinciguerra P.

J Refract Surg. 2003 Mar‐Apr;19(2 Suppl):S227‐30.

Use of amino acids in refractive surgery.

Vinciguerra P, Camesasca FI, Ponzin D. J

Refract Surg. 2002 May‐Jun;18(3 Suppl):S374‐7.

PHASE II 2005 Ist International Study Protocol

TRIAL CE

EUDRA CT Number

Directive 2001/20/EC N°2006‐000640‐12

Participants Number of eyes pre OP: 660 (>1000)

68 pediatric; 35 ectasic (2dmp; 5prk; 3intacs;29 lasik; 2 kr)

age@OP average 30 years (from 9 to 67)

VISUAL ACUITY 1,2

1,1

1,0

BSCVA over Time

sex female 30,53% or 210 eyes male 69,47%or 450 eyes

pre SR equiv: mean -3,79 D ± 4,216 D (from -28,58 to 5,52) pre SR sph: mean -2,44 D ± 4,02 D (from -25,67 to 6,02) pre SR cyl: mean -2,70 D ± 1,91 D (from -9,95 to 0,00)

eyes 1 y: 400 (follow up rate 47,63%) eyes 2 y: 307 (follow up rate 23,35%) eyes 3 y: 90(follow up rate 6,87%) eyes 4 y: 26 (follow up rate 1,98% eyes 5 y: 26 (follow up rate 1,98%)

0,9

0,8

0,7

0,6

0,5

0,4

0,3

0,2

0,46

0,45

0,54

0,55

0,60

0,67

0,73 0,73

D

0,60

pre op 1 m 3 m 6 m 1 y 2 y 3 y 4 y 5 y

Change in BCVA %

«SAFETY» Visual acuity Visual acuity

Spherical changed over time Astigmatism changed over time

D

D D

Sim k1 Sim k2 SRI: baseline vs follow up

SRC: baseline vs follow up SAI: baseline vs follow up Total aberration baseline vs follow up

microns

Course IC 29 – Cross-Linking – Vinciguerra - 6

Change in BSCVA Safety % Change in BSCVA Safety %

20% (9-17) 32% (18-29) 20% (30-39)

28% (9-17) 28% (>40) 23% (18-29) 28% (30-39) 21% (>40)

22% (9-17) Pediatrici 24% (18-29) 18-29 30-39 21% (30-39) >40 33% (>40)

AK ↑ AK ↑ AK ↑ AK ↓ CCT↓ CCT↓ CCT↓ CCT↑

AK ↓ AK ↓ AK ↓ AK ↓

CCT↓ CCT↓ CCT↓ CCT=

AK ↓ AK ↓ AK ↓ CCT↓ CCT↓ CCT=

Pre op Corvis

1 mos post cxl Description of parameters

Reduction of the deformation

1,20 mm 0,96 mm

5,90 ms 6,25 ms

Increased strenght

Increased reflectance

1st A length: is the cord length of the first applanation 2nd A length: is the cord length of the second applanation V in : is the corneal speed during the first applanation moment

V out : is the corneal speed during the second applanation moment W‐Dist: is the distance of the two "knee's" at the highest concavity point Curvature Rad HC: is the (central concave) curvature at the highest concavity point

Def Amp : is the maximum amplitude, so how far was the cornea shifted from the start point to the highest concavity point.

CORVIS PARAMETERS

6,00

5,00

4,00

3,00

2,00

1,00

Time CORVIS PARAMETERS second

25

20

15

10

5 0

INTRAOP RESULTS CH and CRF

0,00 1 st A lenght

2nd A lenght

V in V out W-Dist Curv Rad

HC

Def Amp 1st A-time 2st A-time HC-time

pre CXL 5,67 22,19 17,32 pre CXL 1,76 1,63 0,13 0,45 5,39 4,68 1,28 post CXL 1,73 1,50 0,11 0,39 3,17 1,00 1,35

post CXL 5,62 21,27 17,31

1st A‐time : is the time from starting until the first applanation (This delivers also the IOP‐NCT value)

p>0.05

p<0.05 p<0.05 p<0.05

2nd A‐time : is the time from starting until the second applanation

preCXL with

preCXL sine

After staining

After UVA ir

After RE-EPI

POSTOP RESULTS CH and CRF INTRAOP RESULTS Peaks POSTOP RESULTS Peak 1 and 2 AK ↑ AK ↑ AK ↓ CCT↓ CCT↓ CCT↑

p<0.05

p<0.05

PRE XL

PRE XL POST XL 1 month 6 months 12 months 24 months

p<0.05

p<0.05

p<0.05

WITH EPI Wout EPI Wout EPI POST XL POST XL POST XL POST XL preCXL preCXL After After p>0.05 p<0.05 p<0.05 p>0.05 p>0.05 p>0.05 with sine CXL RE-EPI

By age….

Loss>1

Change in BSCVA Safety %

unchanged

BSCVA:line change over time

by curvature group

By curvature group….

Spherical equivalent change over time by curvature group

Spherical change over time by curvature group

Astigmatism change over time by curvature group

ΔD ΔD ΔD

Course IC 29 – Cross-Linking – Vinciguerra - 7

Post CXL

BSCVA:line change over time by pachymetry group

Spherical change over time by thinnest point value group

ΔD

By thinnest point value group….

Astigmatism change over time by thinnest point value group

Spherical equivalent change over time by thinnest point value

group

Packing of lamellae in normals, keratoconus and after CXL

ΔD ΔD

NORMAL Kc

CXL

NORMALE Kc

CXL

Effects of riboflavin/UVA corneal cross-linking on keratocytes and collagen fibres in human cornea. Mencucci R, Marini M, Paladini I, Sarchielli E, Sgambati E, Menchini U, Vannelli GB.

Clin Experiment Ophthalmol. 2010 Jan;38(1):49-56. Lectin binding in normal, keratoconus and cross-linked human corneas.

Mencucci R, Marini M, Gheri G, Vichi D, Sarchielli E, Bonaccini L, Ambrosini S, Zappoli Thyrion GD, Paladini I, Vannelli GB, Sgambati E. Acta Histochem. 2010 Jan 4 According to Rita Mencucci, 2006

Collagen diameter increase after CXL (nm)

Transition line of keratoconus post cxl over time

in different pts

Post cxl + lac

12,2 %

4,6 %

340μ in cornea

1 yrs post cxl

292μ in cornea

2 yrs post cxl

404μ in cornea

328μ in cornea

(Wollensak,Spoerl,Seiler: Cornea 2004)

3 yrs post cxl

3,5 yrs post cxl

Deep opacity after CXL Haze post PRK

100µ Striae after cxl

296µ

Apparent corneal thinning

“Thinning” is only temporary because: Riboflavine solution contain dextrane

that together with the exposure to air of the denuded cornea dehydrates the stroma Collagen fibers and lamellae are packed

by CXL

Corneal thickness normalization Epithelium takes weeks to return to normal thickness

Stroma rehydrates

Increase of fiber diameter due to CXL

Corneal thickness can even increase with time (1‐2 years)

Pachymetry map shows a more physiological distribution with time

Reduction of the TRUE NET power of the keratoconus overtime

49.3 D 48.8 D 46.0 D 46.3 D

Pre op cxl 1 mos post cxl 3 mos post cxl 6 mos post cxl 46.8 D 46.1 D

12 mos post cxl 24 mos post cxl

pt n° 75

Differential map from pre op cxl to 2 yrs post cxl

Reduction of the area/power of the keratoconus overtime

BSCVA is better, even if curvature pattern improvement is not so big

Reduction of pachimetry map over time of the keratoconus post cxl with expansion

+3.65 D -4.15 D -6.18 D Pre cxl

0.4 -3.00 sph

1 mos post cxl

0.4 -3.00 sph

3 mos post cxl

0.4 -3.00 sph

8 mos post cx

0.9 +0.75 3.00(115) Pre cxl 1 mos post cxl 3 mos post cxl 9 mos post cxl

385µ 272µ 287µ 275µ

1°examination pre cxl 1 mos post‐

op

3 mos post

52,9 D 55,0 (+2,1) D 51,8 (-0,9) D 52,4 (-0,5) D

Differential tangential map:

0.3 +2.50 (-4.25)80 0.3 -2.00 (-5.00) 80 0.4 -1.50 (-4.50)80 0.6 -1.50 (-4.50)80

Differential pachimetry map Corneal pachymetry is

6 mos post 12 mos post 24 mos post -5.17 D -6.08 D -6.61 D

pt n° 138 Differential map from pre cxl to 24 mos post cxl

only – 0,5 D!!!

pt n° 154

pt n° 305

reduced even if is observed BSCVA gain and reduction of K values (see next)

-110 µ

Course IC 29 – Cross-Linking – Vinciguerra - 8

map

Paolo Vinciguerra M.D.

Paolo Vinciguerra M.D.

pre cxl 0,8 – 1,25@94

1 mos post cxl 0,6 +7,00 ‐1,00@90

6 mos post cxl 0,9 nat

Instantaneus map over time

Pre op 3 day post ptk+ cxl 2 mos post ptk+cxl

0,1 -7.00 (-2.00)30 0,4 -4.00 (-1,50)38 0,6 -1,50 (-

4 mos post ptk+cxl 11 mos post ptk+cxl 1,50)20

-14.46 D

0,5 -2,75(- 0,8 -1.50(- 2.00)11 2.00)20

-33.97 D

pre cxl

0,8 – 1,25@94

1 mos post cxl

0,6 +7,00 ‐1,00@90 6 mos post cxl 0,9 nat

3 mm

Pre op 2 mos post Ptk+Cxl

+ 0.575 µ + 0.100 µ

Reduction of coma aberration -0.475µ

Reduction of the area/power of the keratoconus overtime

Differential tangential map: -9.6 D

Cxl over time: from keratoconus to irregular astigmatism

Pre cxl (44,57 D) 1 mos post cxl (+1,02 D) 3 mos post cxl (-0,37 D)

Coma reduction overtime 1.685 µ 1.096 µ 1.029 µ

1.0 -2.25@7 0,9 -0,75 -2.00@20 0,9 -2,50@15 6 mos post cxl (-0,14 D) 1 yrs post cxl (-3,42 D)

Pre op cxl 1 mos post cxl 3 mos post cxl

1.079 µ 1.013 µ 0.934 µ

Differential Tangential map

from pre op to 1yrs post cxl -3,42 D

+63.5 D + +58 D (-5.4 D) +53.9(-9.6 D)

0,9 con -2,50 @15 1.0 con -2.00@10

pt n° 75

6 mos post 12 mos post cxl 24 mos post cxl

coma reduction of the 44.57 %

Differential instantaneus

BSCVA is better even if there is an apparent corneal thinning

Pre op 2 mos post Ptk+Cxl

OSV 0.6 -6.00 -1.00@120

OSV 1.0

-0.25 Look peripherical treatmant

474 µ -176 µ +94 µ

Differential instantaneus map

Pre op 3 mos post Ptk+Cxl

Zone 3 mm order 8

Pre op 3 mos post Ptk+Cxl

OSV 0.7 -1.75@11 OSV 0.7 -0.75@68

+0.575 µ +0.100 µ

-10.13 D

Paolo Vinciguerra M.D.

Course IC 29 – Cross-Linking – Vinciguerra - 9

Instantaneus map over time

Pre op 3 day post ptk+ cxl 2 mos post ptk+cxl

0,1 -7.00 (-2.00)30 0,4 -4.00 (-1,50)38 0,6 -1,50 (-1,50)20

4 mos post ptk+cxl 11 mos post ptk+cxl

-14.46 D

0,5 -2,75(-2.00)11 0,8 -1.50(-2.00)20

-33.97 D Fluctuation of aberrations over

time zone 5 order 8

Pre op 3 day post 2 mos post 4 mos post

0,1 -7.00 (-2.00)30

0,4 -4.00 (-1,50)38

0,5 -2,75(-2.00)11

0,6 -1,50 (-1,50)20

2,117 μ 1,403 μ 0,555 μ 0,349 μ Reduction of the 83,5% (‐1,768μ)

from pre op to 4 mos post ptk+ cxl

Visual acuity over time Pre op 3 day post ptk+ cxl

0,1 -7.00 (-2.00)30 0,4 -4.00 (-1,50)38 2 mos post ptk+cxl 4 mos post ptk+cxl

0,5 -2,75(-2.00)11 0,6 -1,50 (-1,50)20

III. Simoultaneous Custom Ablation and Cross-Linking

Simultaneous Custom and

CXL

Number of eyes pre OP: 9

age@OP average 35 years (from 22 to 44)

sex female 22,2% or 2 eyes male 77,8% or 7 eyes

pre SR equiv: mean -3,00 D ± 3,83 D (from -8,25 to 2,63) pre SR sph: mean -1,83 D ± 3,98 D (from -7,00 to 4,50) pre SR cyl: mean -2,33 D ± 1,70 D (from -5,00 to 0,00)

month (eyes)

60%

50%

40%

30%

20%

10%

38%

33%33%

25%

17%

25%

1

33%

50% 1

33%

13%

Paolo Vinciguerra M.D.# eyes 3 m: 6 (follow up rate 66,7%)

1 (8) 3 (6) 0 0

Silvia Trazza Orth.#

# Istituto Clinico Humanitas University of Milan , Italy

post SR equiv: mean -0,67 D ± 1,54 D (from -3,75 to 0,50) post SR sph: mean -0,04 D ± 1,47 D (from -2,75 to 1,50) post SR cyl: mean -1,25 D ± 1,30 D (from -3,50 to 0,00)

0% 9 (3) 12 (2)

Change in BSCVA - Percentage 'SAFETY'

Fluctuation of zernike ab over time

Paolo Vinciguerra M.D.

Fluctuation Wf/Corn/tot over time Change in refraction over time Patient n°1 ♂ 44 aa

Pt F:V:

Fingerprint Keratopaty + keratoconus Pre op 4 mos post ptk+ cxl

Paolo Vinciguerra M.D.

Keratoscopy over time

Pre op 3 day post ptk+ cxl

Axial map over time Pre op 3 day post ptk+ cxl

0,1 -7.00 (-2.00)30 0,4 -4.00 (-1,50)38 0,1 -7.00 (-2.00)30 0,4 -4.00 (-1,50)38

2 mos post ptk+cxl 4 mos post ptk+cxl 2 mos post ptk+cxl 4 mos post ptk+cxl

0,5 -2,75(-2.00)11 0,6 -1,50 (-1,50)20

0,5 -2,75(-2.00)11 0,6 -1,50 (-1,50)20

Fluctuation of the aberrations over time

Flucuation over time of True net power

Pre op 3 days post ptk+ cxl

2 mos post ptk+cxl

4 mos post ptk+cxl

10 mos post ptk+cxl

Pre op 3 day post ptk+ cxl

2 mos post ptk+cxl

4 mos post ptk+cxl

1,283μ 0,935μ 0,673μ 0,482μ 0,415μ

0,1 -7.00 (-2.00)30

0,4 -4.00 (-1,50)38

0,5 -2,75(-2.00)11

0,6 -2,75(-2.00)11

0,8 -1.50(-2.00)20

0,1 -7.00 (-

0,4 -4.00 0,5 -

0,6 -1,50

2.00)30 (-1,50)38 2,75(-2.00)11 (-1,50)20

Differential true net power : -7,50 D

Fluctuation over time of pachimetry map Zonal refraction over time Pre op 3 day post ptk+ cxl

Pre op 3 day post ptk+ cxl

2 mos post ptk+cxl

4 mos post ptk+cxl

0,1 -7.00 (-2.00)30

0,4 -4.00 (-1,50)38

0,5 - 2,75(-2.00)11

0,6 -1,50 (-1,50)20

2 mos post ptk+cxl 4 mos post ptk+cxl

Differential pachimetry map: -128 micron From pre op to 4 mos post ptk + cxl

Course IC 72 – Cross-Linking – Vinciguerra - 10

3 mm

Pre op 2 mos post Ptk+Cxl

+ 0.575 µ + 0.100 µ

Reduction of coma aberration -0.475µ

Patient n°2 ♂ 34 aa

Pt F.G. Differential instantaneus map Pre op 2 mos post Ptk+Cxl

Esiti PRK OO 1999 (pre op ODV 1.0 -3.00 -0.25@90

OSV 0.9 -7.00 Ptk+CXL 11/12/2009

OSV pre 0.6 -6.00 -1.00@120 OSV 1 mos 1.0 -0.25

OSV 0.6 -6.00 -1.00@120

OSV 1.0 -0.25

Look at peripheral treatment

Elevation front map Pre op 2 mos post Ptk+Cxl

Differential elevation front map

Pre op 2 mos post Ptk+Cxl

Pre op 2 mos post Ptk+Cxl

Differential Pachymetry map

Pachymetry map:

-183µ

Advanced KC ODV: 0.1 -14.00 (-3.00) 45

Advanced KC

Oct SA custom + cxl 1 mos post

68µ

240 µ

492 µ

400µ

360 µ

204 µ

Patient n°3 ♂ 37 aa

Keratoconus diagnosed in 2006. No CL Ptk+Cxl 14/12/2009

OSV pre 0.7 (-1.75)@11 OSV pre 0.7 (-0.75)@68

Differential instantaneus map

Pre op 3 mos post Ptk+Cxl

OSV 0.7 -1.75@11 OSV 0.7 -0.75@68

Pre op 3 mos post Ptk+Cxl

Improved ring

regularity

OSV 0.7 -1.75@11 OSV 0.7 -0.75@68

-10.13 D

Zone 3 mm order 8 Zone 6 mm order 8

Pre op 3 mos post Ptk+Cxl

Pre op 3 mos post Ptk+Cxl

Pre op 3 mos post Ptk+Cxl

+0.575 µ +0.100 µ +3.346 µ +1.175 µ

Course IC 72 – Cross-Linking – Vinciguerra - 11

Paolo Vinciguerra M.D.

Paolo Vinciguerra M.D. Paolo Vinciguerra M.D.

Paolo Vinciguerra M.D.

Paolo Vinciguerra M.D.

Zone 8 mm order 8

Pre op 3 mos post Ptk+Cxl

Change in true net map over time

Pre op

+5.637 µ +3.848µ

1 mos post custom+cxl

Difference From preop to 6 mos post custom+cxl

6 mos post custom+cxl

Paolo Vinciguerra M.D.

Paolo Vinciguerra M.D.

Pre op 1 mos post custom+ cxl

Reduction of the deformation

Change in Belin indices & keratometric Power Deviation

Change in elevation anterior map over time

Increased strenght

Increased reflectance

Difference From preop to 6 mos post custom+cxl

Paolo Vinciguerra M.D.

Paolo Vinciguerra M.D.

Change in elevation posterior map over time

Difference From preop to 6 mos post custom+cxl

Paolo Vinciguerra M.D.

Paolo Vinciguerra M.D.

Paolo Vinciguerra M.D.

Course IC 72 – Cross-Linking – Vinciguerra - 12

Addresses

Paolo Vinciguerra, MD Chairman, Ophthalmology Dept. Istituto Clinico Humanitas Office: Via Ripamonti, 205 - 20100 Milano - Italy Ph + 39 02 55211388 - Fax +39 02 57410355 [email protected] - www.paolovinciguerra.com - www.refractiveonline.it

Fabrizio I. Camesasca, MD Ophthalmology Dept. Istituto Clinico Humanitas Office: P.za Maria Adelaide, 1 - 20129 Milano - Italy Ph +39 02 29529396 - Fax +39 02 29529396 [email protected] - www.camesasca.com

Jorge L. Alio Vissum Instituto Oftalmologico de Alicante Avenida de Denia s/n Edificio Vissum 03016 Alicante - Spain [email protected]


Recommended